Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K, Harmatz JS, Shader RI: Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. British Journal of Clinical Pharmacology, July 1999, 48. vsk, nro 1, s. 89–97. PubMed:10383565. PubMed Central:2014868. doi:10.1046/j.1365-2125.1999.00953.x. ISSN 0306-5251.
Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K, Harmatz JS, Shader RI: Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. British Journal of Clinical Pharmacology, July 1999, 48. vsk, nro 1, s. 89–97. PubMed:10383565. PubMed Central:2014868. doi:10.1046/j.1365-2125.1999.00953.x. ISSN 0306-5251.
Zolpidem. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012. Teoksen verkkoversio (viitattu 28.11.2023).
pubmed.ncbi.nlm.nih.gov
Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K, Harmatz JS, Shader RI: Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. British Journal of Clinical Pharmacology, July 1999, 48. vsk, nro 1, s. 89–97. PubMed:10383565. PubMed Central:2014868. doi:10.1046/j.1365-2125.1999.00953.x. ISSN 0306-5251.
Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K, Harmatz JS, Shader RI: Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. British Journal of Clinical Pharmacology, July 1999, 48. vsk, nro 1, s. 89–97. PubMed:10383565. PubMed Central:2014868. doi:10.1046/j.1365-2125.1999.00953.x. ISSN 0306-5251.